Oruka Therapeutics, Inc. ORKA Options canceled (in dollars per share)
Options canceled (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s options canceled (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s options canceled (in dollars per share)?
- Oruka Therapeutics, Inc. (ORKA) reported options canceled (in dollars per share) of $15.04 in Q1 2026.
- What does options canceled (in dollars per share) mean?
- Represents the weighted average exercise price of share-based awards that were forfeited or expired during the period. This metric provides context on the value of the underlying equity that failed to vest or be exercised. It helps investors understand the historical pricing of incentive packages that did not result in equity issuance.